3.Clinical Experience of Professor PAN Liqun in the Treatment of Plasma Cell Mastitis
Journal of Nanjing University of Traditional Chinese Medicine 2018;34(2):199-201
This study introduced the clinical experience of Professor PAN Liqun in the treatment of plasma cell mastitis. Professor PAN believes that the treatment should take the understanding of the pathological anatomy as the precondition,take patients'pathogenesis as the basis and combine their menstrual cycles,then expel the toxin through tuofa.At the same time, external therapy should be applied in the treatment,especially the drainage through a small incision following the direction of the breast lesion,which can avoid the massive damage of patients'breast structure particularly the breast ducts,minimize the breast damage and maintain the physical integrity of the breast.Professor PAN's treatment fully plays the academic advantages of the combination of internal and external treatment of traditional Chinese medicine.
5.5-Fu activates NKG2D ligands MICA/B promoter in transiently transfected A549 cell line
Dan, LUO ; Jing-Xiang, ZHAO ; Guang-Zhi, WEI ; Yan, ZHANG ; Zi-Ling, WANG
Bulletin of The Academy of Military Medical Sciences 2009;33(6):535-538
Objective:To analyze the activities of human NKG2D ligand MICA/B promoter induced by 5-Fu.Methods:The 5'-end flanking regions of MICA /B promoter and their different truncated fragments were amplified from A549 genome by PCR. The resulting amplicons were cloned into pGL3-Basic vector to generate the MICA/B luciferase reporter plasmids. All the constructs were transiently transfected A549 cells. The promoter region activities were determined by dual-luciferase reporter assays. The effect of 5-Fu on the promoter activities of MICA/B was also tested.Results and Conclusion:The 5'-end flanking regions of MICA /B promoter and five of their different truncated fragments were successfully obtained. The normalized luciferase reporter gene activities driven by the above promoters and fragments were 3.61,2.26,1.63,0.313,0.711 and 0.663 for MICA and 17.49,10.11,7.398,0.822,0.997 and 0.49 for MICB,respectively. Promoter activities in transiently transfected A549 cells treated by 20,40,80,160 and 320 μg/m of 5-Fu increased 1.69,1.48,1.62,1.55 and 1.78 fold for MICA and 1.44,1.87,1.38,1.19 and 1.25 fold for MICB. Our results suggest that 5-FU can significantly up-regulate the promoter activity of both MICA and MICB.
6.Human umbilical vein endothelial cells support hematopoiesis and expansion of hematopoietic stem/progenitor cells in vitro
Hong-feng, YUAN ; Zi-kuan, GUO ; Xiao-dan, LIU ; Shuang-xi, ZHANG ; Ying, WU ; Ning, MAO
Bulletin of The Academy of Military Medical Sciences 2001;25(1):45-49
Objective: To investigate the role of human umbilical vein endothelial cells (HUVEC) in supporting hematopoiesis and the expansion of hematopoietic stem/progenitor cells in vitro. Methods: According to the fact that HUVEC supernatant has colony stimulating activity shown by methylcellulose colony-forming assay and HUVEC can maintain the survival of mononuclear cells for at least four weeks in vitro, CD34+ cells from umbilical cord blood were seeded with (HUVEC group) or without (control group) HUVEC monolayer. Every week cells were collected and counted, the frequency of CFU-GM was measured by using methylcellulose colony-forming assay, and the percentage of CD34+ and CD41a+ cells was measured by flow cytometry. Results: In control group,all the CD34+ cells died in two weeks. However, in HUVEC group,most nucleated cells and CD34+ cells were expanded by 68.1±14.8 fold and 6.6±1.4 fold,respectively at the third week while CFU-GM expansion reached its peak (5.7±2.1 fold) at the week 2. Moreover, the percentage of CD41a+ cells was enhanced significantly, reaching a maximum (15.6%) at the week 3. Conclusions:HUVEC can support hematopoiesis in vitro and expand the hematopoietic progenitor cells and CD41a+ cells in direct contact coculture.
7.Maternal periodontal disease and risk of preeclampsia: A meta-analysis.
Xi, HUANG ; Juan, WANG ; Jian, LIU ; Li, HUA ; Dan, ZHANG ; Ting, HU ; Zi-Li, GE
Journal of Huazhong University of Science and Technology (Medical Sciences) 2014;34(5):729-35
Research on the association between maternal periodontal disease and the risk of preeclampsia has generated inconsistent results. This meta-analysis was conducted to evaluate the association between maternal periodontal disease and the risk of preeclampsia. A literature search of PubMed and Embase was performed to identify relevant papers published before March 2013. Only observational studies that assessed maternal periodontal disease and the risk of preeclampsia were selected. Patients' periodontal status was examined at different time points during pregnancy or after delivery (at 14-32 weeks of gestation, within 48 h prior to or within 5 days after delivery). Pooled odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated for cases and controls. Cases were defined as women with concurrent hypertension and proteinuria after 20 weeks of gestation. Eleven studies involving 1118 women with preeclampsia and 2798 women without preeclampsia were identified and analyzed. Women with periodontal disease before 32 weeks of gestation had a 3.69-fold higher risk of developing preeclampsia than their counterparts without periodontal disease (OR=3.69; 95% CI=2.58-5.27). Periodontal disease within 48 h prior to delivery was associated with a 2.68-fold higher risk of preeclampsia (OR=2.68; 95% CI=1.39-5.18). Pregnant women with periodontal disease within 5 days after delivery had a 2.22-fold higher risk of preeclampsia than women without periodontal disease (OR=2.22; 95% CI=1.16-4.27). In conclusion, this meta-analysis suggests that maternal periodontal disease is an independent predictor of preeclampsia.
8.Clinical characteristics and prevention of ocular penetrating injuries in children
Man-Hong, LI ; Zi-Feng, ZHANG ; Yu-Sheng, WANG ; Dan, HU
International Eye Science 2017;17(8):1580-1583
AIM: To analyze the clinical features of children ocular penetrating trauma,and hope to effectively assist to prevent pediatric ocular trauma METHODS: The data of 145 cases (145 eyes) with ocular penetrating trauma,hospitalized in Xijing Hospital from January 2012 to December 2016,were collected and retrospectively analyzed.All the data of injury factors and environment,age and gender of patients,lesions,treatment and prognosis were detailed studied.RESULTS: In all the 145 pediatric patients with ocular penetrating trauma,accounted for 8.5% of all the ocular trauma patients,there were 95 cases of male,and 50 of female.Penetrating injuries mainly occurred in age of 3-9.The main injuries of ocular perforating in children were scissors,and sharp objects of wooden and iron.The wound was often located in the cornea or the anterior sclera.Traumatic cataract,vitreous hemorrhage and endophthalmitis were the common complications.The visual acuity was severely damaged,and 90 cases (62.1%) of the children recovered better than 0.1 after effective treatment.CONCLUSION: The visual function of pediatric p0atients was seriously threatened after penetrating injuries.However,the damage of vision and the rate of blindness can be reduced effectively after timely and correct diagnosis and treatment.It is the most important that active and effective prevention in keep children away from penetrating injuries.
9.Study of the clonal origin and development of MDS by FISH analysis of dysplasia cells in bone marrow of patients with MDS.
Chun-Mei FU ; Zi-Xing CHEN ; Dan-Dan LIU ; Jun ZHANG ; Jin-Lan PAN
Journal of Experimental Hematology 2013;21(3):650-656
This study was purpose to explore whether the dysplasia of myelodysplastic syndromes (MDS) is unspecific feature or results of the abnormal clone, and to provide the evaluation of abnormal clone changes in bone marrow cells of MDS patients. The dysplasia cells in bone marrow smears was analyzed by morphologic observation, the clonal origin and development in 16 cases of MDS with abnormality of chromosome karyotypes were investigated by FISH combined with morphologic observation. The results found that both the dysplastic and nondysplastic bone cells displayed abnormal clones in the erythroid and granulocytic cells. The dysplastic bone marrow cells displayed more abnormal clones than the nondysplastic bone marrow cells in most of the patients, and the abnormal clones displayed more dysplastic cells than the normal clones. Most of the dysplastic and nondysplastic megakaryocytes were derived from abnormal clones. The abnormal clone showed a decreasing trend from the primitive stage to the terminal stage of cell differentiation. It is concluded that there is a correlation between the dysplastic cells and the abnormal clones in MDS, but the dysplasia of bone marrow cells is not a specific feature. The abnormal clones can differentiate into mature granulocytes and erythrocytes, and can be in coexistence with cells originated from the normal clones.
Adult
;
Aged
;
Bone Marrow Cells
;
cytology
;
pathology
;
Bone Marrow Examination
;
Clone Cells
;
Female
;
Humans
;
In Situ Hybridization, Fluorescence
;
Karyotyping
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
blood
;
genetics
;
Young Adult
10.Bioinformatics of mouse uteroglobin binding protein and its polyclonal antibody preparation.
Chen LI ; Wei LIU ; Jian-Zhong HAN ; Dan-Dan FENG ; Hui-Jun LIU ; Zi-Qiang LUO
Acta Physiologica Sinica 2013;65(2):217-223
To prepare anti-mouse uteroglobin binding protein (mUGBP) polyclonal antibody, two polypeptides were synthesized based on the bioinformatics analysis of mUGBP, and New Zealand white rabbits were immunized separately with each peptide coupled with keyhole limpet hemocyanin (KLH). The data indicate that a 13-amino acid polypeptide (positions 221st-233rd) was able to generate anti-peptide antibodies. The titer of the antisera detected with ELISA was 1:10(8). The antisera were then purified with immuno-affinity chromatography to obtain antibodies. Western blot analysis of mUGBP expressed as a fusion protein with a green fluorescent protein (GFP) was performed on the cell lysates of COS-1 cells with the purified antisera, suggesting that the antisera specifically recognized UGBP. By immunohistochemistry and indirect immunofluorescence analysis, we examined the expression of UGBP in the lung tissues from a patient undergoing surgical lung resection for a tumor and from normal mouse lung tissue, and found for the first time that UGBP protein was widely expressed in both mouse and human lung tissue with the most abundant expression in bronchial epithelial cells. These results suggest that the antigen epitopes of mUGBP are well predicted by using bioinformatics analysis. We have obtained anti-mUGBP polyclonal antibody, which will be useful for further investigation.
Animals
;
Antibodies
;
chemistry
;
COS Cells
;
Carrier Proteins
;
chemistry
;
Cercopithecus aethiops
;
Computational Biology
;
Enzyme-Linked Immunosorbent Assay
;
Hemocyanins
;
Humans
;
Immune Sera
;
Immunohistochemistry
;
Mice
;
Rabbits
;
Recombinant Proteins
;
chemistry
;
Uteroglobin